| Study on the Optimization of the Diagnostic Process for Chronic Rhinitis Using Nasal Allergen Provocation Test (NCT06999044) | The First Affiliated Hospital with Nanjing Medical University | 2025-03-24 |
| Effect of Digital Therapeutics for Cardiac Rehabilitation in Patients With Acute Myocardial Infarction (NCT06772337) | The First Affiliated Hospital with Nanjing Medical University | 2025-03-01 |
| Risk Prediction Model of MACE in Patients With AMI Based on Multi-modal Machine Learning (NCT06767852) | The First Affiliated Hospital with Nanjing Medical University | 2025-03-01 |
| Behavior Change Wheel-Based Music Listening for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients (NCT07641114) | The First Affiliated Hospital with Nanjing Medical University | 2025-03-01 |
| Pulmonary Vein Isolation in Typical Atrial Flutter and Heart Failure (NCT06817447) | The First Affiliated Hospital with Nanjing Medical University | 2025-03-01 |
| A Multicenter Prospective Randomized Controlled Clinical Trial Comparing Constant (5%) Versus Sequential (5%-2%) Oxygen Concentration Embryo Culture Protocols in Assisted Reproductive Technology (NCT07050537) | The First Affiliated Hospital with Nanjing Medical University | 2025-03-01 |
| Gestational Lifestyle & Outcomes Wellness (NCT07263412) | The First Affiliated Hospital with Nanjing Medical University | 2025-02-25 |
| A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11 (NCT06759636) | The First Affiliated Hospital with Nanjing Medical University | 2025-02-24 |
| Chronic Remote Ischemic Conditioning in Small Infarctions Associated with Stent-assisted Coiling of Unruptured Intracranial Aneurysms (NCT06826144) | The First Affiliated Hospital with Nanjing Medical University | 2025-02-20 |
| Early Clinical Study of JY306 Universal NK Cell Injection in the Treatment of Adult Relapsed or Refractory CD70+ Malignant Hematologic Tumors (NCT06837389) | The First Affiliated Hospital with Nanjing Medical University | 2025-02-15 |
| Analysis of Factors Associated With the Efficacy of 595-nm Pulsed Dye Laser Treatment for Rosacea (NCT07410533) | The First Affiliated Hospital with Nanjing Medical University | 2025-02-01 |
| SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer. (NCT06835179) | The First Affiliated Hospital with Nanjing Medical University | 2025-02-01 |
| A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing (NCT07036731) | The First Affiliated Hospital with Nanjing Medical University | 2025-02-01 |
| Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery (NCT06762782) | The First Affiliated Hospital with Nanjing Medical University | 2025-02-01 |
| Hypofractionated Radiation Fractionation in Breast Cancer Patients With Implant-Based Reconstruction (NCT06830083) | The First Affiliated Hospital with Nanjing Medical University | 2025-01-30 |
| Multi-Technology Integrated Total Mesorectal Excision Versus Conventional Total Mesorectal Excision for the Treatment of Middle and Distal Rectal Cancer. (NCT06613399) | The First Affiliated Hospital with Nanjing Medical University | 2025-01-01 |
| Prospective Study on Exemption of Tumor Bed Boost Radiotherapy for pCR Patients After Breast Conserving Surgery With Neoadjuvant Therapy (NCT07113613) | The First Affiliated Hospital with Nanjing Medical University | 2025-01-01 |
| Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer. (NCT07394387) | The First Affiliated Hospital with Nanjing Medical University | 2025-01-01 |
| To Evaluate the Effectiveness and Safety of Mastectomy Combined With Immediate Breast Reconstruction in Breast Cancer (NJMU-Reconstruction Cohort) (NCT06817954) | The First Affiliated Hospital with Nanjing Medical University | 2025-01-01 |
| Linperlisib Combination With Cyclophosphamide, Prednisone, and Thalidomide (CPT) in R/R NHL (NCT07195799) | The First Affiliated Hospital with Nanjing Medical University | 2024-12-31 |
| Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases (NCT06715007) | The First Affiliated Hospital with Nanjing Medical University | 2024-12-20 |
| Microbial Study of Sublingual Immunotherapy Tablets in Patients With Allergic Rhinitis (NCT06741800) | The First Affiliated Hospital with Nanjing Medical University | 2024-12-20 |
| Neoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC (NCT06699498) | The First Affiliated Hospital with Nanjing Medical University | 2024-12-03 |
| Microbial Study of Sublingual Immunotherapy Spray in Patients With Allergic Rhinitis (NCT06741787) | The First Affiliated Hospital with Nanjing Medical University | 2024-12-01 |
| Comparing the Incidence of Parastomal Hernia After Mesenteric Molding Suturing and Non-molding Suturing in Colostomy Surgery (NCT06674187) | The First Affiliated Hospital with Nanjing Medical University | 2024-12-01 |
| Using ctDNA to Guide Treatment Decisions for Stage III Gastric Cancer (NCT06939439) | The First Affiliated Hospital with Nanjing Medical University | 2024-12-01 |
| Xiangtong TM Full Degradation Sinus Drug Stent System Prospective, Open, Single-center, Randomized Controlled Clinical Trial (NCT06669130) | The First Affiliated Hospital with Nanjing Medical University | 2024-12-01 |
| Correlation Analysis of Xpert Carba-R Detection of Non-colonized CRE in BALF and Rectal Swabs From Patients With LRTI (NCT06636890) | The First Affiliated Hospital with Nanjing Medical University | 2024-12-01 |
| Prospective Study on the Safety and Efficacy of Robot-Assisted Laparoscopic Partial Nephrectomy With Renal Artery Off-Clamp in the Treatment of cT1 Renal Tumors (NCT06908902) | The First Affiliated Hospital with Nanjing Medical University | 2024-12-01 |
| To Evaluate the Effectiveness and Safety of Single-port Robotic-assisted Subcutaneous Gland Resection Combined With Immediate Breast Reconstruction in Breast Cancer (NCT06706726) | The First Affiliated Hospital with Nanjing Medical University | 2024-12-01 |
| A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer (NCT06735287) | The First Affiliated Hospital with Nanjing Medical University | 2024-12-01 |
| Mecapegfilgrastim Combined With Adebrelimab and Chemotherapy as Neoadjuvant Therapy in Resectable GC/GEJC (NCT06684158) | The First Affiliated Hospital with Nanjing Medical University | 2024-11-30 |
| Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion Immunochemotherapy (NCT07056010) | The First Affiliated Hospital with Nanjing Medical University | 2024-11-25 |
| Donafenib Combined With Capecitabine for Postoperative Adjuvant Therapy of Biliary Malignant Tumors With High-risk Recurrence Risk (NCT06685289) | The First Affiliated Hospital with Nanjing Medical University | 2024-11-15 |
| Impact of Pet Cats on Nasal and Gut Microbiota in Patients With Cat Allergen Allergy (NCT07110311) | The First Affiliated Hospital with Nanjing Medical University | 2024-11-14 |
| Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy (NCT06895447) | The First Affiliated Hospital with Nanjing Medical University | 2024-11-14 |
| Diagnostic Efficacy of CDA Nasal Provocation Test in Patients With IR (NCT06682676) | The First Affiliated Hospital with Nanjing Medical University | 2024-11-07 |
| Characteristic Transcriptomic, Proteomic and Metabolomic Molecular Studies of Nasal Secretions From Chronic Rhinitis (NCT06678334) | The First Affiliated Hospital with Nanjing Medical University | 2024-11-06 |
| The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase I Clinical Study (NCT06770296) | The First Affiliated Hospital with Nanjing Medical University | 2024-11-01 |
| Ultrasound-Enhanced Delivery of Compound TXA Solution in Melasma (NCT07202156) | The First Affiliated Hospital with Nanjing Medical University | 2024-10-20 |
| Adebrelimab Combined With Irinotecan Liposomal (II), Oxaliplatin, and 5-FU/LV Conversion Therapy for Locally Advanced Pancreatic Cancer (NCT06766019) | The First Affiliated Hospital with Nanjing Medical University | 2024-10-16 |
| Neoadjuvant Short-Course Radiotherapy Followed by CAPOX Plus PD-1 Antibody and IL-2 in Locally Advanced Rectal Cancer (PRIDE01) (NCT06577194) | The First Affiliated Hospital with Nanjing Medical University | 2024-10-09 |
| The Efficacy and Mechanism of SMA+M1 Repetitive Transcranial Magnetic Stimulation on Freezing of Gait in PD (NCT06415682) | The First Affiliated Hospital with Nanjing Medical University | 2024-10-08 |
| A Study Comparing the Efficacy and Safety of Pola-RCHP-X Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With DLBCL (NCT06516978) | The First Affiliated Hospital with Nanjing Medical University | 2024-10-01 |
| Application of Electronic Endoscope in Fetal Distress (NCT06608654) | The First Affiliated Hospital with Nanjing Medical University | 2024-10-01 |
| Multi-parametric Functional MRI in Patients of Chronic Kidney Disease (NCT06639685) | The First Affiliated Hospital with Nanjing Medical University | 2024-10-01 |
| Multi Center Clinical Study on the Lipid-lowering Efficacy and Safety of Menggongzi Tibetan Tea Special Drink (NCT06551298) | The First Affiliated Hospital with Nanjing Medical University | 2024-10-01 |
| Interventional Treatment of Chronic Tinnitus With Acoustic Stimulation (NCT07185061) | The First Affiliated Hospital with Nanjing Medical University | 2024-10-01 |
| Effects of an Information-Based Discharge Service on Preterm Infants, Parents, and Hospitals (NCT06613386) | The First Affiliated Hospital with Nanjing Medical University | 2024-10-01 |
| Molecular Subtype-Guided R-CHOP-MTX±Zanubrutinib Treatment in Newly Diagnosed DLBCL Patients with Central Nervous System Involvement (NCT06594432) | The First Affiliated Hospital with Nanjing Medical University | 2024-10-01 |
| Comparison of Nerve-sparing Techniques in Radical Prostatectomy for Oncological Outcome and Functional Recovery. (NCT06524219) | The First Affiliated Hospital with Nanjing Medical University | 2024-10-01 |
| Brachial Versus Femoral Access for Carotid Artery Stenting (NCT06557135) | The First Affiliated Hospital with Nanjing Medical University | 2024-09-27 |
| Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACHIEVE (NCT06607276) | The First Affiliated Hospital with Nanjing Medical University | 2024-09-20 |
| Neoadjuvant Therapy for Locally Advanced Rectal Cancer (NCT06853769) | The First Affiliated Hospital with Nanjing Medical University | 2024-09-01 |
| To Evaluate the Effectiveness and Safety of the Single-port Robotic-assisted Breast Surgery in Breast Cancer (NCT06561646) | The First Affiliated Hospital with Nanjing Medical University | 2024-08-21 |
| MRI and CT in Gastroesophageal Junction or Upper Gastric Adenocarcinoma (NCT06640153) | The First Affiliated Hospital with Nanjing Medical University | 2024-08-21 |
| Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes (NCT06891157) | The First Affiliated Hospital with Nanjing Medical University | 2024-08-20 |
| Assessment of Efficacy and Safety of PD-1 Monoclonal Antibody Combined With IL-2 and CapeOX in Neoadjuvant Therapy for Locally Advanced Rectal Cancer Prior to Surgery: A Prospective, Multi-center, Randomized Controlled Study (NCT06884670) | The First Affiliated Hospital with Nanjing Medical University | 2024-08-18 |
| Efficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HER2-negative Advanced Breast Cancer (Rachel) (NCT06656624) | The First Affiliated Hospital with Nanjing Medical University | 2024-08-13 |
| Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Methotrexate in Breast Cancer With Leptomeningeal Metastasis (NCT06543992) | The First Affiliated Hospital with Nanjing Medical University | 2024-08-08 |
| A Single-arm, Phase II Exploratory Study of Sintilimab in Combination With Chemoradiotherapy in Elderly Patients With Locally Advanced Gastric Cancer (NCT06555471) | The First Affiliated Hospital with Nanjing Medical University | 2024-08-06 |
| A Study on the Combination of Sintilimab, Ramucirumab and Chemotherapy for First-line Treatment of Gastric Cancer With Liver Metastasis (NCT06564298) | The First Affiliated Hospital with Nanjing Medical University | 2024-08-01 |
| To Evaluate the Efficacy of Adebrelimab Combined With Chemotherapy After HIFU Induction Neoadjuvant Therapy HR+/HER2- Breast Cancer (NCT06470633) | The First Affiliated Hospital with Nanjing Medical University | 2024-08-01 |
| FUS-TB VS COG-TB in Small Lesions of Prostate Cancer (NCT06504017) | The First Affiliated Hospital with Nanjing Medical University | 2024-08-01 |
| CPVI With Modified Linear Ablation Versus CPVI in Patients With Long-standing Persistent Atrial Fibrillation (SINUS) (NCT06516822) | The First Affiliated Hospital with Nanjing Medical University | 2024-07-31 |
| On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of Lymphoma (NCT06503211) | The First Affiliated Hospital with Nanjing Medical University | 2024-07-31 |
| HeartMed-HF Digital Therapeutics Improves Exercise Capacity in CHF Patients After AMI (NCT06478732) | The First Affiliated Hospital with Nanjing Medical University | 2024-07-30 |
| Current Status of BTKi Treatment for CLL/SLL in China (NCT06508684) | The First Affiliated Hospital with Nanjing Medical University | 2024-07-13 |
| Application of PD-1 Monoclonal Antibody in Combination With IL-2 and CapeOX in Organ Preservation Therapy for Ultra-Low Localized Advanced Rectal Cancer (NCT06504875) | The First Affiliated Hospital with Nanjing Medical University | 2024-07-10 |
| Evaluation of Efficacy and Safety of PD-1 Monoclonal Antibody in Combination With rhG-CSF, IL-2, and CapeOX in Initially Resectable Synchronous Colorectal Liver Metastases (NCT06504901) | The First Affiliated Hospital with Nanjing Medical University | 2024-07-10 |
| Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer (NCT06569459) | The First Affiliated Hospital with Nanjing Medical University | 2024-07-09 |
| Effect of Repetitive Transcranial Magnetic Stimulation on Neurological Recovery in Patients With Ischaemic Stroke (NCT06415734) | The First Affiliated Hospital with Nanjing Medical University | 2024-07-01 |
| Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes (NCT06532682) | The First Affiliated Hospital with Nanjing Medical University | 2024-07-01 |
| LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma (NCT06472479) | The First Affiliated Hospital with Nanjing Medical University | 2024-07-01 |
| Efficacy of Auricular Acupuncture Therapy in the Prevention of CIPN in Breast Cancer (NCT07092111) | The First Affiliated Hospital with Nanjing Medical University | 2024-07-01 |
| The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy (NCT06461377) | The First Affiliated Hospital with Nanjing Medical University | 2024-06-13 |
| Study on the Mechanism of ZhenQiFuZheng in the Treatment of Allergic Rhinitis Based on Intestinal Flora and Metabolites (NCT06427577) | The First Affiliated Hospital with Nanjing Medical University | 2024-06-01 |
| The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM (NCT06427252) | The First Affiliated Hospital with Nanjing Medical University | 2024-05-31 |
| Screening of Biomarkers and Related Mechanisms for RIX (NCT06700863) | The First Affiliated Hospital with Nanjing Medical University | 2024-05-17 |
| Research on the Brain Mechanism of taVNS in Regulating PD Motor Symptoms (NCT06409338) | The First Affiliated Hospital with Nanjing Medical University | 2024-05-11 |
| Evaluation of The Efficacy And Safety of PD-1 + IL-2 Combined With Capox Treatment After Loop Colostomy Surgery in Left-sided Colorectal Cancer Patients Complicating Acute Obstruction (NCT06394791) | The First Affiliated Hospital with Nanjing Medical University | 2024-05-01 |
| RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric Cancer (NCT06385873) | The First Affiliated Hospital with Nanjing Medical University | 2024-05-01 |
| IVC and Lung Ultrasound B-lines Guided Decongestion in Critically Ill ESKD Patients With Heart Failure (NCT06373575) | The First Affiliated Hospital with Nanjing Medical University | 2024-05-01 |
| A Prospective Study Comparing DRd With VRd-lite in Elderly Newly Diagnosed Multiple Myeloma (NCT06497738) | The First Affiliated Hospital with Nanjing Medical University | 2024-05-01 |
| Obeservational Cohort for Evaluating Future Cardiovascular Disease With High Metabolic Risks (NCT06385431) | The First Affiliated Hospital with Nanjing Medical University | 2024-04-28 |
| HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer (NCT06383078) | The First Affiliated Hospital with Nanjing Medical University | 2024-04-20 |
| A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLL (NCT05950997) | The First Affiliated Hospital with Nanjing Medical University | 2024-04-16 |
| The Development of Tinnitus in Patients With SSNHL: Insights From fMRI and Metabolomics (NCT06355102) | The First Affiliated Hospital with Nanjing Medical University | 2024-04-15 |
| Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (NCT06295549) | The First Affiliated Hospital with Nanjing Medical University | 2024-04-11 |
| Trilaciclib for the Prevention of Chemoradiotherapy-Induced Myelosuppression in Esophageal Squamous Cell Carcinoma (NCT06698692) | The First Affiliated Hospital with Nanjing Medical University | 2024-04-02 |
| Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM (NCT06341595) | The First Affiliated Hospital with Nanjing Medical University | 2024-04-01 |
| Aerobic Dance During Chemotherapy in Breast Cancer Patients With Cognitive Impairment (NCT06234150) | The First Affiliated Hospital with Nanjing Medical University | 2024-04-01 |
| Predicting Ventilator-associated Lower Respiratory Tract Infection Outcomes Using Sequenced-based Early Microbiological Response (NCT06467864) | The First Affiliated Hospital with Nanjing Medical University | 2024-04-01 |
| Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma (NCT06988956) | The First Affiliated Hospital with Nanjing Medical University | 2024-03-31 |
| A Multi-omics Study of "Healthy" Premature CAD Patients (NCT06362278) | The First Affiliated Hospital with Nanjing Medical University | 2024-03-20 |
| Study on the Staging and Prognosis Model of Bladder Cancer (NCT06565923) | The First Affiliated Hospital with Nanjing Medical University | 2024-03-18 |
| Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients (NCT06479460) | The First Affiliated Hospital with Nanjing Medical University | 2024-03-08 |
| The Effects of Social Isolation and Social Interaction on the Risk of Dementia Progression and Brain Function in SCD (Subjective Cognitive Decline, SCD) (NCT06335836) | The First Affiliated Hospital with Nanjing Medical University | 2024-03-01 |
| Immunotherapy for Hepatocellular Carcinoma (NCT06241326) | The First Affiliated Hospital with Nanjing Medical University | 2024-03-01 |
| The Efficacy and Adverse Reactions of Neotetracycline in the Treatment of GNB Infections (NCT06990126) | The First Affiliated Hospital with Nanjing Medical University | 2024-03-01 |